Evidence map›Paper›PMID 40687184›Full record

ReviewVeterinary medicine international2025

Diagnosis and Treatment of Benign Prostatic Hyperplasia in Dogs: New Approaches.

Nooshin Derakhshandeh, Asghar Mogheiseh, Saeed Nazifi

Abstract readReview
In one paragraph

Review in Veterinary medicine international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nooshin DerakhshandehDepartment of Clinical Sciences, School of Veterinary Medicine, Shiraz University, Shiraz, Iran.ORCID https://orcid.org/0000-0003-1752-6028
Asghar MogheisehDepartment of Clinical Sciences, School of Veterinary Medicine, Shiraz University, Shiraz, Iran.ORCID https://orcid.org/0000-0002-3136-2288
Saeed NazifiDepartment of Clinical Sciences, School of Veterinary Medicine, Shiraz University, Shiraz, Iran.ORCID https://orcid.org/0000-0002-5501-1028

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review aims to define the best prescription options for the treatment and diagnosis of benign prostatic hyperplasia (BPH) in dogs. BPH has become the most common disease in older dogs. While it rarely poses life-threatening risks, it can significantly impact a patient's quality of life, as changes in prostate size can lead to various clinical signs, including tenesmus, constipation, and hematuria. An accurate initial evaluation and diagnostic method are essential for distinguishing BPH from other conditions and differential diagnoses. Treatment modalities include both medical and surgical options. In recent years, medical therapy for BPH has expanded and improved. The focus of medical treatment is to reduce prostatic volume, alleviate bothersome clinical sign, and prevent the need for surgical intervention, especially for dogs that are still used for breeding. The pharmacological effects, efficacy, and safety of these treatments must be thoroughly analyzed to ensure good drug adherence and persistence.

Indexed as

BPHdiagnosisdogstreatment

Identifiers

PMID40687184
PMCPMC12271692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.